Literature DB >> 24078004

MiR-25 promotes gastric cancer cells growth and motility by targeting RECK.

Hongying Zhao, Yu Wang, Liu Yang, Rongke Jiang, Wenqing Li.   

Abstract

Gastric cancer (GC) is the second leading cause of cancer-related death worldwide. Recently, accumulating evidence suggests that microRNAs (miRNAs) play prominent roles in tumorigenesis and metastasis. Here, we confirmed that miR-25 was significantly increased in human GC tissues and cell lines. Forced expression of miR-25 remarkably enhanced cell proliferation, migration, and invasion in GC cells, whereas inhibition of miR-25 by inhibitor caused significant suppression of proliferation and significant increase of apoptosis. Moreover, inhibition of miR-25 significantly decreased migration and invasion of GC cells. Finally, reversion-inducing-cysteine-rich protein with kazal motifs (RECK) was found to be a target of miR-25. Overexpression of RECK could significantly reverse the oncogenic effect of miR-25. Taken together, miR-25 might promote GC cells growth and motility partially by targeting RECK.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24078004     DOI: 10.1007/s11010-013-1829-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  27 in total

1.  Melatonin attenuates scopolamine-induced memory/synaptic disorder by rescuing EPACs/miR-124/Egr1 pathway.

Authors:  Xiong Wang; Zhi-Hao Wang; Yuan-Yuan Wu; Hui Tang; Lu Tan; Xiang Wang; Xin-Ya Gao; Yan-Si Xiong; Dan Liu; Jian-Zhi Wang; Ling-Qiang Zhu
Journal:  Mol Neurobiol       Date:  2012-10-07       Impact factor: 5.590

2.  MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Xiaohui Xu; Zhaoli Chen; Xiaohong Zhao; Jiwen Wang; Dapeng Ding; Zhen Wang; Fengwei Tan; Xiaogang Tan; Fang Zhou; Jian Sun; Nan Sun; Yibo Gao; Kang Shao; Ning Li; Bin Qiu; Jie He
Journal:  Biochem Biophys Res Commun       Date:  2012-03-17       Impact factor: 3.575

3.  Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK.

Authors:  Na Li; Bin Tang; En-Dong Zhu; Bo-sheng Li; Yuan Zhuang; Shu Yu; Dong-shui Lu; Quan-Ming Zou; Bin Xiao; Xu-Hu Mao
Journal:  FEBS Lett       Date:  2012-02-02       Impact factor: 4.124

4.  Pancreatitis-associated protein inhibits human pancreatic stellate cell MMP-1 and -2, TIMP-1 and -2 secretion and RECK expression.

Authors:  Ling Li; Max G Bachem; Shaoxia Zhou; Zilin Sun; Jinfei Chen; Marco Siech; Daniel Bimmler; Rolf Graf
Journal:  Pancreatology       Date:  2008-12-12       Impact factor: 3.996

Review 5.  RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer.

Authors:  Jonathan C M Clark; David M Thomas; Peter F M Choong; Crispin R Dass
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

6.  MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma.

Authors:  Liang Zhou; Zhao-Xu Yang; Wen-Jie Song; Qing-Jun Li; Fan Yang; De-Sheng Wang; Ning Zhang; Ke-Feng Dou
Journal:  Int J Oncol       Date:  2013-05-27       Impact factor: 5.650

7.  MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN.

Authors:  Ting-Song Yang; Xiao-Hu Yang; Xu-Dong Wang; Yi-Ling Wang; Bo Zhou; Zhen-Shun Song
Journal:  Cancer Cell Int       Date:  2013-07-08       Impact factor: 5.722

8.  STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells.

Authors:  H-Y Lin; C-H Chiang; W-C Hung
Journal:  Br J Cancer       Date:  2013-07-02       Impact factor: 7.640

9.  Oncogenic miRNA-182-5p targets Smad4 and RECK in human bladder cancer.

Authors:  Hiroshi Hirata; Koji Ueno; Varahram Shahryari; Yuichiro Tanaka; Z Laura Tabatabai; Yuji Hinoda; Rajvir Dahiya
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

Review 10.  Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).

Authors:  Masaru Katoh
Journal:  Int J Mol Med       Date:  2013-07-16       Impact factor: 4.101

View more
  52 in total

1.  MicroRNA screening identifies circulating microRNAs as potential biomarkers for osteosarcoma.

Authors:  Hui Li; Kun Zhang; Li-Hong Liu; Yurong Ouyang; Hong-Bin Guo; Hanchong Zhang; Jie Bu; Tao Xiao
Journal:  Oncol Lett       Date:  2015-06-16       Impact factor: 2.967

2.  Role of microRNAs in diagnosis and treatment of the pathogenesis of gastric cancer.

Authors:  Gang Chen; Yong Tang; Jiang-Hua Wu; Feng-Hua Liu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

Review 3.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

4.  MicroRNA-126 regulates migration and invasion of gastric cancer by targeting CADM1.

Authors:  Zhen Yang; Ruoming Wang; Tengteng Zhang; Xinhua Dong
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

5.  MiR-145 inhibits osteosarcoma cells proliferation and invasion by targeting ROCK1.

Authors:  Enqi Li; Jinli Zhang; Tianxiang Yuan; Baotong Ma
Journal:  Tumour Biol       Date:  2014-05-07

6.  MiR-96 downregulates RECK to promote growth and motility of non-small cell lung cancer cells.

Authors:  Haizhou Guo; Qianping Li; Weihao Li; Tianliang Zheng; Song Zhao; Zhangsuo Liu
Journal:  Mol Cell Biochem       Date:  2014-01-29       Impact factor: 3.396

7.  MicroRNA-25 contributes to cisplatin resistance in gastric cancer cells by inhibiting forkhead box O3a.

Authors:  Jingbo He; Huixiong Qi; Fang Chen; Chuanhua Cao
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

8.  The expression of miR-25 is increased in colorectal cancer and is associated with patient prognosis.

Authors:  Xiaojun Li; Chunyan Yang; Xiaoqiang Wang; Jian Zhang; Ruipeng Zhang; Ruiting Liu
Journal:  Med Oncol       Date:  2013-11-29       Impact factor: 3.064

Review 9.  Small molecules targeting microRNA for cancer therapy: Promises and obstacles.

Authors:  Di Wen; Michael Danquah; Amit Kumar Chaudhary; Ram I Mahato
Journal:  J Control Release       Date:  2015-08-06       Impact factor: 9.776

10.  miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2.

Authors:  Huimin Lu; Ling Zhang; Shan Lu; Dujiang Yang; Jun Ye; Mao Li; Weiming Hu
Journal:  Exp Ther Med       Date:  2020-03-11       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.